Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity

Francesco Orio, Giovanna Muscogiuri, Stefano Palomba, Silvia Savastano, Alessio Volpe, Marcello Orio, Giorgio Colarieti, Giovanni Battista La Sala, Annamaria Colao, Francesca Marciano, Antonio Ascione, Pietro Putignano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p

Original languageEnglish
Journale-SPEN Journal
Volume8
Issue number5
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Berberine
Polycystic Ovary Syndrome
Insulin Resistance
Alkaloids
Testosterone
Body Mass Index
Therapeutics
Insulin

Keywords

  • Berberine
  • BMI
  • FAI
  • Insulin resistance
  • PCOS
  • Testosterone

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity. / Orio, Francesco; Muscogiuri, Giovanna; Palomba, Stefano; Savastano, Silvia; Volpe, Alessio; Orio, Marcello; Colarieti, Giorgio; La Sala, Giovanni Battista; Colao, Annamaria; Marciano, Francesca; Ascione, Antonio; Putignano, Pietro.

In: e-SPEN Journal, Vol. 8, No. 5, 10.2013.

Research output: Contribution to journalArticle

Orio, F, Muscogiuri, G, Palomba, S, Savastano, S, Volpe, A, Orio, M, Colarieti, G, La Sala, GB, Colao, A, Marciano, F, Ascione, A & Putignano, P 2013, 'Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity', e-SPEN Journal, vol. 8, no. 5. https://doi.org/10.1016/j.clnme.2013.07.002
Orio, Francesco ; Muscogiuri, Giovanna ; Palomba, Stefano ; Savastano, Silvia ; Volpe, Alessio ; Orio, Marcello ; Colarieti, Giorgio ; La Sala, Giovanni Battista ; Colao, Annamaria ; Marciano, Francesca ; Ascione, Antonio ; Putignano, Pietro. / Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity. In: e-SPEN Journal. 2013 ; Vol. 8, No. 5.
@article{2932729c52f44995986fb371d8465995,
title = "Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity",
abstract = "Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p",
keywords = "Berberine, BMI, FAI, Insulin resistance, PCOS, Testosterone",
author = "Francesco Orio and Giovanna Muscogiuri and Stefano Palomba and Silvia Savastano and Alessio Volpe and Marcello Orio and Giorgio Colarieti and {La Sala}, {Giovanni Battista} and Annamaria Colao and Francesca Marciano and Antonio Ascione and Pietro Putignano",
year = "2013",
month = "10",
doi = "10.1016/j.clnme.2013.07.002",
language = "English",
volume = "8",
journal = "e-SPEN",
issn = "2212-8263",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity

AU - Orio, Francesco

AU - Muscogiuri, Giovanna

AU - Palomba, Stefano

AU - Savastano, Silvia

AU - Volpe, Alessio

AU - Orio, Marcello

AU - Colarieti, Giorgio

AU - La Sala, Giovanni Battista

AU - Colao, Annamaria

AU - Marciano, Francesca

AU - Ascione, Antonio

AU - Putignano, Pietro

PY - 2013/10

Y1 - 2013/10

N2 - Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p

AB - Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p

KW - Berberine

KW - BMI

KW - FAI

KW - Insulin resistance

KW - PCOS

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84884906815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884906815&partnerID=8YFLogxK

U2 - 10.1016/j.clnme.2013.07.002

DO - 10.1016/j.clnme.2013.07.002

M3 - Article

AN - SCOPUS:84884906815

VL - 8

JO - e-SPEN

JF - e-SPEN

SN - 2212-8263

IS - 5

ER -